SPIRONOLACTONE ALTIZIDE PFIZER 25 mg/15 mg, scored tablet 90 tablets
Active ingredients: Altizide, Spironolactone
Commercialized according to BDPMDispensing in France: Prescription only
Scored tablet90 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- SPIRONOLACTONE ALTIZIDE PFIZER 25 mg/15 mg, comprimé sécable
- Pharmaceutical form
- comprimé sécable
- Route of administration
- orale
- Presentation description
- plaquette(s) PVC-Aluminium de 90 comprimé(s)
- Marketing authorisation holder
- PFIZER HOLDING FRANCE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 13 Feb 2026
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67623353CIP73729693CIP133400937296939Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| SPIRONOLACTONEcomprimé | 25 mg · un comprimé | SA |
| ALTIZIDEcomprimé | 15 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.